Prospective Multicenter Study of the Safety of Gadoteridol in 6163 Patients

BACKGROUND: The safety of gadolinium‐based contrast agents is of fundamental importance. PURPOSE: To determine the frequency and severity of immediate‐type adverse reactions to approved doses of gadoteridol in patients referred for routine gadoteridol‐enhanced MRI in actual clinical practice setting...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Sung Bum, Lee, A‐Leum, Chang, Hyuk Won, Kim, Kyeong Ah, Yoo, Won Jong, Yeom, Jeong A., Rho, Myung Ho, Kim, Sung Jin, Lim, Yun‐jung, Han, Miran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027821/
https://www.ncbi.nlm.nih.gov/pubmed/31663202
http://dx.doi.org/10.1002/jmri.26940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027821/
https://www.ncbi.nlm.nih.gov/pubmed/31663202
http://dx.doi.org/10.1002/jmri.26940

Ejemplares similares